Cargando…

A Case of Myelodysplastic Syndrome with Intestinal Behçet’s Disease-Like Symptoms Treated by Prednisolone and Azacitidine

Patient: Female, 68 Final Diagnosis: Myelodysplastic Syndrome with Intestinal Behçet’s Disease-Like Symptoms Symptoms: Abdominal pain • fever • oral ulcer Medication: — Clinical Procedure: CT • bone marrow examination • colonoscopy Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: Intestinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Masatsugu, Sekikawa, Akira, Tsumura, Takehiko, Maruo, Takanori, Osaki, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662094/
https://www.ncbi.nlm.nih.gov/pubmed/26590106
http://dx.doi.org/10.12659/AJCR.895431
Descripción
Sumario:Patient: Female, 68 Final Diagnosis: Myelodysplastic Syndrome with Intestinal Behçet’s Disease-Like Symptoms Symptoms: Abdominal pain • fever • oral ulcer Medication: — Clinical Procedure: CT • bone marrow examination • colonoscopy Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: Intestinal Behçet’s disease-like symptoms are rare complications of myelodysplastic syndrome and are often refractory to immunosuppressive therapies. We described a case of myelodysplastic syndrome complicated by Behçet’s disease-like symptoms treated with prednisolone and azacitidine. CASE REPORT: A 68-year-old Japanese woman was admitted to our hospital because of persistent high fever and lower abdominal pain. Oral ulcerations developed after admission, and multiple ulcers were found in her terminal ileum by endoscopic examination. She was diagnosed with myelodysplastic syndrome with trisomy 8 by bone marrow examination. Her symptoms diminished after administration of prednisolone, but relapsed afterwards. She began azacitidine therapy and her symptoms have been controlled for at least 10 months. CONCLUSIONS: This case might suggest the possibility of azacitidine as a treatment option for myelodysplastic syndrome complicated by Behçet’s disease-like symptoms.